If the Supreme Court gives drug companies the freedom to promote off-label prescriptions for anything for which they can gin up a study, the scope for which many medications are prescribed for off-label use will widen broadly, experts warn. “Harm will happen” under such a scenario, Soller says, because consumers will be even more in the dark about what medication they take and why the medications are prescribed. We’d call that a tough pill to swallow.
Elizabeth Weise has written about health and science for USA Today since 2002. She also investigated food fraud in the May/June 2012 issue of Consumers Digest.